349 related articles for article (PubMed ID: 14716961)
21. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
Gentlesk MJ; Halpern GM; Mansmann HC
Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
[TBL] [Abstract][Full Text] [Related]
22. [Bee and wasp venom allergy].
Baumgartner A; Wokalek H; Schöpf E
Fortschr Med; 1989 Jul; 107(21):460-3. PubMed ID: 2670712
[TBL] [Abstract][Full Text] [Related]
23. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
24. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
Ring J; Lonsdorf G; Schury W; Burg G
MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
[No Abstract] [Full Text] [Related]
25. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
Müller UR; Golden DB; Demarco PJ; Lockey RF
Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
[No Abstract] [Full Text] [Related]
27. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
[TBL] [Abstract][Full Text] [Related]
28. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
[TBL] [Abstract][Full Text] [Related]
29. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors for allergy to hymenoptera stings].
Leveau P
Allerg Immunol (Paris); 1993 Jun; 25(6):220, 224-6. PubMed ID: 8357470
[TBL] [Abstract][Full Text] [Related]
31. [Therapy control of specific hymenoptera venom allergy].
Aust W; Wichmann G; Dietz A
Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
[TBL] [Abstract][Full Text] [Related]
32. [Results of hyposensitization with bee and wasp venom].
Adolph J; Dehnert I; Fischer JF; Wenz W
Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
[TBL] [Abstract][Full Text] [Related]
33. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
van der Brempt X; Ledent C; Mairesse M
Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
[TBL] [Abstract][Full Text] [Related]
34. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
[TBL] [Abstract][Full Text] [Related]
35. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
Urra JM; Cabrera CM; Alfaya T; Feo-Brito F
Mol Immunol; 2016 Feb; 70():134-9. PubMed ID: 26774053
[TBL] [Abstract][Full Text] [Related]
36. Natural history of Hymenoptera venom allergy in Eastern Spain.
Fernandez J; Soriano V; Mayorga L; Mayor M
Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
[TBL] [Abstract][Full Text] [Related]
37. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
[No Abstract] [Full Text] [Related]
38. Prevalence of Hymenoptera venom allergy and its immunological markers current in adults in Poland.
Nittner-Marszalska M; Liebhart J; Liebhart E; Dor A; Dobek R; Obojski A; Medrala W
Med Sci Monit; 2004 Jul; 10(7):CR324-9. PubMed ID: 15232507
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome after venom immunotherapy.
Golden DB
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):337-41. PubMed ID: 20610978
[TBL] [Abstract][Full Text] [Related]
40. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]